Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial.

dc.contributor.authorWiese, Michael D
dc.contributor.authorHeddle, Robert John
dc.contributor.authorBrown, Simon G A
dc.contributor.authorBlackman, K E
dc.date.accessioned2010-07-27T06:12:38Z
dc.date.available2010-07-27T06:12:38Z
dc.date.issued2003en_US
dc.description.note84 THEOBALDS RD, LONDON, ENGLAND, WC1X 8RRen
dc.identifier.citationBrown, S.G., Wiese, M.D., Blackman, K.E., & Heddle, R.J., 2003. Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial. Lancet, 361, 1001-1006.en
dc.identifier.doihttps://doi.org/10.1016/S0140-6736(03)12827-9en
dc.identifier.issn0140-6736en_US
dc.identifier.rmid2003052099en_US
dc.identifier.urihttp://hdl.handle.net/2328/10674
dc.subject.forgroup1100 Medical And Health Sciencesen_US
dc.subject.forgroup1107 Immunologyen_US
dc.titleAnt venom immunotherapy: a double-blind, placebo-controlled, crossover trial.en_US
dc.typeArticleen_US
Files